Compare · APGB vs EUCR
APGB vs EUCR
Side-by-side comparison of Apollo Strategic Growth Capital II (APGB) and Eucrates Biomedical Acquisition Corp. (EUCR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APGB and EUCR operate in Blank Checks (Finance), so they compete in similar markets.
- APGB is the larger of the two at $836.6M, about 6.4x EUCR ($131.6M).
Apollo Strategic Growth Capital II
Apollo Strategic Growth Capital II intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as APH I (Sub I), Ltd. and changed its name to Apollo Strategic Growth Capital II in December 2020. Apollo Strategic Growth Capital II was incorporated in 2008 and is based in New York, New York.
Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest APGB
- SEC Form SC 13G/A filed by Apollo Strategic Growth Capital II (Amendment)
- SEC Form SC 13G/A filed by Apollo Strategic Growth Capital II (Amendment)
- SEC Form SC 13G filed by Apollo Strategic Growth Capital II
- SEC Form 15-12G filed by Apollo Strategic Growth Capital II
- SEC Form 25-NSE filed by Apollo Strategic Growth Capital II
- SEC Form 10-Q filed by Apollo Strategic Growth Capital II
- Apollo Strategic Growth Capital II filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Apollo Strategic Growth Capital II Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination; Per-Share Redemption Price For The Public Shares Will Be ~$10.58
- Apollo Strategic Growth Capital II Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination
- SEC Form 10-Q filed by Apollo Strategic Growth Capital II
Latest EUCR
- SEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.
- Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Eucrates Biomedical Acquisition Corp. Announces Liquidation
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
- SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)